News and Updates

Michael West, CEO of BioTime, Inc., schedules key stem cell licensing topics for conference call.

Plans are underway at The Anthony Nolan Trust Cord Blood Bank at Nottingham Trent University in England for a major processing and storage facility of cord blood.

The combined results of two independent groups of researchers represent major progress in the development of safer, more efficiently produced iPS (induced pluripotent stem) cells.

Sir Ian Wilmut and Dr. Shinya Yamanaka are among those honored at a glittering ceremony in Hong Kong for their pioneering work.

A controversial embryonic stem cell company in Massachusetts fights to survive as it struggles with increasing debt.

In a visually dramatic graphical representation, Drs. Rudolf Jaenisch and Christopher Lengner describe and contrast the properties of embryonic stem cells and pluripotent cells derived from non-embryonic sources.